|
Grant Writing Workshop,
Coaching, and Networking
Pharmaceutical * Biotechnology * Life Sciences
Wednesday, September 25, 2002, 2-5 p.m.
WTC Office 1207 Indiana Street, S.F. CA 94107
$60 includes workshop, refreshments and networking
Space is Limited - Please register early at
www.acteva.com/go/wtc
Expert grant writers with decades of experience and millions of
dollars in grant awards will reveal numerous secrets of successful
grant writing
provide individualized coaching for specific aims share important
organizational and writing skills.
The Grant Writing Workshop will teach you to:
- Define optimal project for funding
- Find potential grant opportunities
- Match proposal to ideal grant
program
- Elaborate each component of the
grant
- Emphasize novel aspects of your
technology
- Formulate focused and precise
specific aims
- Develop flow chart of experimental
design
- Use clear, concise, and strong
language
Cori Gorman, Ph.D., MBA, of
DNA Bridges, Inc. is an expert in gene expression and protein
productions as well as gene transfer include ding gene therapy. She
has first hand knowledge about the review process for federal grants
having served on an SBIR review committee at the NIH for over five
years. Ina addition to being a successful PI on five SBIR grants,
she has coached others in grant writing so that they have also been
successful in obtaining funds in the millions. Cori has worked at
Genentech, was a founder of Valentis, a gene therapy company, and is
one of the most highly cited scientists in the past two decades with
more than 10,000 citations.
Eileen Gorman, Ph.D., USPTO
Registered Patent Agent, of DNA Bridges, Inc., is an expert in
technology development from inception to commercialization based on
positions at NIH and industry. With a strong technical background in
biochemistry, and real business leadership roles, she has helped
clients keep grant applications focused on basic business goals. She
attends the national SBIR conference held by NIH each year and has
worked with clients to raise millions in federal funding over the
last 5 years
Shauna Farr-Jones, Ph.D., of
BioIntelligence, is a biochemist with experience in academic
research, business development, and medical writing. She specializes
in drug discovery technologies including microarrays, high
throughput screening, and SNP detection. Previously, she analyzed
and wrote about strategic market issues affecting biotechnology
companies for BioCentury Publications. Her academic research focused
on protein structure determination using NMR and bioinformatics
software for structural biology studies.
Gail Schechter, Ph.D., of
BioIntelligence, is a neuroscientist with experience in the
pharmaceutical industry, academic medicine, and the National
Institutes of Health. As President of BioIntelligence for the past
10 years, she has written millions of dollars of successful grants
for many small companies. Previously, she worked at Genentech, was a
clinical faculty member at the Stanford University School of
Medicine in the Department of Psychiatry, and spent ten years doing
neuropharmacology research at the NIH.
Sponsored jointly by DNA Bridges,
BioIntelligence, and the
WTC.
 |
|

Highlights

DNA Bridges Articles

Calendar of Events

Archives
2010 |
2009 |
2008 |
2007 |
2006 |
2005 |
2004
2003 |
2002 |
2001 |
2000

|